109 results
8-K
EX-99.1
ALGS
Aligos Therapeutics Inc
7 May 24
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
4:05pm
due to a decrease in employee related costs, partially offset by an increase in third party expenses. Total R&D stock-based compensation expense
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
Units
Reserved
for Future
Issuance
Pursuant
to New
Grants
Under the
2020 Incentive
Award Plan
Reserved
for Future
Issuance
Pursuant
to 2020
Employee …
Issuance
Pursuant
to 2020
Employee
Stock
Purchase
Plan
Pre-Reverse Stock Split
Post-Reverse Stock Split 1 for 5
Post-Reverse Stock Split 1 for 15
S-8
ALGS
Aligos Therapeutics Inc
12 Mar 24
Registration of securities for employees
4:51pm
Employee Stock Purchase Plan
(Full Title of the Plan)
Lawrence M. Blatt, Ph.D.
President and Chief Executive Officer
Aligos Therapeutics, Inc.
One … to eligible employees of the Registrant under the Registrant’s 2020 Employee Stock Purchase Plan (the “ESPP”). Shares available for issuance under
S-8
p9k7fpr 7cqwjl3x
12 Mar 24
Registration of securities for employees
4:51pm
S-8
EX-5.1
9wr5g54s0y
12 Mar 24
Registration of securities for employees
4:51pm
S-8
EX-23.2
c63zq wz8n6jk
12 Mar 24
Registration of securities for employees
4:51pm
SC TO-I
EX-99
23rz7k6ezhamq
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
u3k2k
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
iabu8p
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
2kmj8xfjhiwup
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
dz96zpbduy 4zv
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
z7zf6gauu1yq676eizw
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
2lgcllk0vhevjg4o0
30 Jan 24
Issuer tender offer statement
7:04am